文献速递血脂与心血管预防冠心病

多种慢性炎症性疾病与心血管及2型糖尿病发病和全因死亡的关系

Cardiovascular and type 2 diabetes morbidity and all-cause mortality among diverse chronic inflammatory disorders.
PubMed 文献 · Heart · 2017-06-10

SLE与多种心血管代谢疾病的关联最强(RR 6.36,95%CI 4.37-9.25),使用NSAIDs或糖皮质激素者关联更强;特定炎症性疾病的全因死亡率高于无炎症性疾病者。

要点

  • SLE与多种心血管代谢疾病风险关联最强,RR为6.36(95%CI 4.37-9.25)。
  • 使用NSAIDs或糖皮质激素者中,SLE的多种心血管代谢风险RR达12.35(95%CI 7.18-21.24)。
  • 特定炎症性疾病的全因死亡率高于无炎症性疾病者。

核心结论

  • 炎症性疾病与心血管代谢事件风险升高相关,且可能因抗炎治疗和病程而异。
  • 特定炎症性疾病的全因死亡率高于无炎症性疾病者。

研究设计与样本

  • 基于英国生物银行数据的横断面研究(估计心血管代谢风险)和前瞻性队列研究(估计死亡风险)。

主要发现

  • SLE与多种心血管代谢疾病风险关联最强(RR 6.36,95%CI 4.37-9.25),其次为RA(RR 1.70,95%CI 1.59-1.83)、UC(RR 1.69,95%CI 1.51-1.89)、血管炎(RR 1.64,95%CI 1.42-1.90)、AS(RR 1.28,95%CI 1.09-1.52)和银屑病(RR 1.25,95%CI 1.16-1.35)。
  • 使用NSAIDs或糖皮质激素者中,多种心血管代谢风险在SLE中更高(RR 12.35,95%CI 7.18-21.24),其次为UC(RR 3.81,95%CI 2.69-5.38)、克罗恩病(RR 3.07,95%CI 1.85-5.11)、RA(RR 3.06,95%CI 2.44-3.85)、银屑病(RR 2.36,95%CI 1.88-2.95)、AS(RR 2.25,95%CI 1.48-3.41)和血管炎(RR 1.89,95%CI 1.28-2.79)。
  • 累积心血管代谢风险呈现相似模式。
  • 特定炎症性疾病的全因死亡率高于无炎症性疾病者。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The present study aimed to assess the relationship between inflammatory disorders with cardiometabolic diseases and mortality within a community-based population. METHODS: The UK Biobank data were used to conduct two investigations: a cross-sectional study to estimate cardiometabolic risk and a prospective cohort study to estimate mortality risk. Binary regression analyses were used to model the association between coronary heart disease, stroke, type 2 diabetes, venous thromboembolism and peripheral artery disease diagnoses with seven inflammatory disorders (eg, rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), psoriasis, ankylosing spondylitis (AS), systemic vasculitis, Crohn's disease and ulcerative colitis (UC)). Cox proportional hazards was used to estimate all-cause and cardiovascular-related mortality. RESULTS: About 4% (n=19, 082) of the study population (n=5 02 641) were diagnosed with a chronic inflammatory disorder. The most common inflammatory disorder was psoriasis (n=6286), and the least common was SLE (n=654). SLE showed the strongest association with multiple (relative risk (RR) 6.36, 95% CI 4.37 to 9.25) risk of cardiometabolic diseases, followed by the RA (RR 1.70, 95% CI 1.59 to 1.83), UC (RR 1.69, 95% CI 1.51 to 1.89), AS (RR 1.28, 95% CI 1.09 to 1.52), vasculitis (RR 1.64, 95% CI 1.42-1.90) and psoriasis (RR 1.25, 95% 1.16 to 1.35) disorders. The magnitude of the association was higher among participants prescribed non-steroidal anti-inflammatory drugs or corticosteroids drugs, with multiple cardiometabolic risk being greater within SLE (RR 12.35, 95% CI 7.18 to 21.24), followed by UC (RR 3.81, 95% CI 2.69 to 5.38), Crohn's disease (RR 3.07, 95% CI 1.85 to 5.11), RA (RR 3.06, 95% CI 2.44 to 3.85), psoriasis (RR 2.36, 95% CI 1.88 to 2.95), AS (RR 2.25, 95% CI 1.48 to 3.41) and vasculitis (RR 1.89, 95% CI 1.28 to 2.79). Similar pattern was observed with respect to the cumulative cardiometabolic risk. CONCLUSION: Inflammatory disorders are associated with heightened risk of cardiometabolic events, which may vary by anti-inflammatory therapy and duration. All-cause mortality was also higher among specific inflammatory disorders compared with the absence of inflammatory disorders.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Dregan A, Chowienczyk P, Molokhia M, et al. Cardiovascular and type 2 diabetes morbidity and all-cause mortality among diverse chronic inflammatory disorders. Heart. 2017. PMID: 28601812. doi:10.1136/heartjnl-2017-311214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。